TELA Bio, Inc.
NASDAQ:TELA
3.075 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 46.729 | 42.019 | 43.931 | 74.394 | 45.302 | 17.278 | 11.346 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 9.285 | 0 | 0 |
| Cash and Short Term Investments
| 46.729 | 42.019 | 43.931 | 74.394 | 54.587 | 17.278 | 11.346 |
| Net Receivables
| 9.737 | 6.621 | 4.234 | 2.683 | 2.836 | 1.298 | 0.757 |
| Inventory
| 13.162 | 11.792 | 7.658 | 3.907 | 4.603 | 4.348 | 1.815 |
| Other Current Assets
| 2.098 | 2.015 | 3.232 | 2.241 | 2.308 | 0.33 | 0.429 |
| Total Current Assets
| 71.726 | 62.447 | 59.055 | 83.225 | 64.334 | 23.254 | 14.347 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 3.938 | 2.909 | 1.186 | 0.626 | 0.677 | 0.758 | 1.161 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 2.119 | 2.499 | 2.303 | 2.607 | 2.911 | 3.215 | 0 |
| Goodwill and Intangible Assets
| 2.119 | 2.499 | 2.303 | 2.607 | 2.911 | 3.215 | 0 |
| Long Term Investments
| 0.265 | 0 | 0 | 0 | 0 | 0 | 0.024 |
| Tax Assets
| -0.265 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.265 | -5.408 | -3.489 | -3.233 | -3.588 | 0 | 0 |
| Total Non-Current Assets
| 6.322 | 5.408 | 3.489 | 3.233 | 3.588 | 3.973 | 1.185 |
| Total Assets
| 78.048 | 67.855 | 62.544 | 86.458 | 67.922 | 27.227 | 15.532 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 1.667 | 1.534 | 2.414 | 0.652 | 3.171 | 3.421 | 1.507 |
| Short Term Debt
| 0.565 | 0.34 | 0 | 0 | 0 | 0 | 0.905 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 1.589 |
| Other Current Liabilities
| 14.735 | 10.529 | 8.161 | 5.953 | 3.542 | 6.138 | 2.147 |
| Total Current Liabilities
| 16.967 | 12.403 | 10.575 | 6.605 | 6.713 | 9.559 | 6.148 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 40.515 | 39.916 | 31.491 | 30.827 | 30.243 | 29.733 | 3.61 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 1.685 | 1.231 | 0.38 | -30.827 | 0.004 | 125.795 | 113.945 |
| Total Non-Current Liabilities
| 42.2 | 41.147 | 31.871 | 30.827 | 30.247 | 155.528 | 117.555 |
| Total Liabilities
| 59.167 | 53.55 | 42.446 | 37.432 | 36.96 | 165.087 | 123.703 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 67.922 | 124.15 | 111.349 |
| Common Stock
| 0.024 | 0.019 | 0.015 | 0.014 | 0.011 | 0 | 0.007 |
| Retained Earnings
| -320.889 | -274.225 | -229.929 | -196.653 | -167.859 | -137.86 | -108.171 |
| Accumulated Other Comprehensive Income/Loss
| 0.091 | 0.15 | -0.052 | -0.071 | -0.019 | -3.243 | -2.785 |
| Other Total Stockholders Equity
| 339.655 | 288.361 | 250.064 | 245.736 | 130.907 | -120.907 | -108.571 |
| Total Shareholders Equity
| 18.881 | 14.305 | 20.098 | 49.026 | 30.962 | -137.86 | -108.171 |
| Total Equity
| 18.881 | 14.305 | 20.098 | 49.026 | 30.962 | -137.86 | -108.171 |
| Total Liabilities & Shareholders Equity
| 78.048 | 67.855 | 62.544 | 86.458 | 67.922 | 27.227 | 15.532 |